Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
Influenza: Viral Infections: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, QUARZAN to SYPRINE Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS QUARZAN to SYPRINE Trade Name Generic QUARZAN *Clidinium QUESTRAN Cholestyramine QUINAGLUTE Quinidine RAXAR Grepafloxacin REBETRON Ribavirin RECOMBIVAX HB Hepatitis B vaccine REGITINE Phentolamine REGLAN Metoclopramide RELAFEN Nabumetone RELENZA Zanamivir REOPRO Abciximab REQUIP...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs. Salmeterol to Zolpidem Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Salmeterol to Zolpidem Generic Trade Name Salmeterol SEREVENT Salsalate DISALCID, SALFLEX Saquinavir FORTOVASE Sargramostim LEUKINE Secobarbital SECONAL Selegiline ELDEPRYL Selenium SELSUN Sertraline ZOLOFT Sibutramine MERIDIA Sildenafil VIAGRA Silver sulfadiazine SILVADENE Simethicone MYLICON...
Studies Continue to Highlight Hemispherx’s Ampligen® as Broadly Effective Adjuvant to Avian Influenza Treatments Ampligen® Home - | - Corporate Info - | - R & D - | - Products - | - Investor Relations - | - For the Patient - | - Careers at Hemispherx - - Hemispherx Biopharma Press Release for Thursday, November 03, 2005 Studies Continue to Highlight Hemispherx’s Ampligen® as Broadly Effective Adjuvant to Avian Influenza Treatments Ampligen® Demonstrates Strong Therapeutic Synergy with ...
Microsoft Word - Biota appoints new CEO.doc Biota appoints new CEO Melbourne, Australia— 2nd December 2005.Relenza, following worldwide concerns about Avian flu and consequent Government stockpiling of antivirals.
author: kadams
Microsoft Word - Biota appoints new CEO.doc page 2
author: kadams
Current Announcements-Biota Holdings Current Announcements-Biota Holdings Current Announcements-Biota Holdings Relenza, Zanamivir, influenza, flu, RSV, Respiratory Syncytial Virus, clincial trials, influmation programme, BioStar, Glaxo Wellcome, regulatory approval, Rhinovirus, START, common cold, Flu OIA, diagnostic kit, 2nd generation influenza, inhibitors, neuraminidase, Daiichi, FDA, IND, Phase I, Phase...
Oseltamivir or zanamivir for influenza (flu) - [Medication] - Quest Diagnostics Patient Health Library Oseltamivir or zanamivir for influenza (flu) Examples Brand Name Chemical Name Relenza zanamivir Tamiflu oseltamivir phosphate Zanamivir is inhaled through a device called a Diskhaler.zanamivir and oseltamivir have been shown to effectively treat and prevent the flu, although zanamivir is not currently labeled for...
Microsoft Word - BTA-27Oct05-SPP.doc Biota raises $31 million Melbourne, Australia, 27 October 2005 – Biota Holdings Limited (ASX: BTA) announced today that it had raised approximately $31 million from its Share Purchase Plan (SPP), which closed on 12 October.
author: kadams
Microsoft Word - GSK update-16 Sept 2005.doc For immediate release Reported stockpiling orders Melbourne, Australia, 16 September 2005 Biota Holdings Limited (ASX: BTA) announced today that it is providing a market update on the status of reported stockpiling orders based on information from its commercial partner, GlaxoSmithKline (GSK).
author: driddell
Microsoft Word - Press release 29 Aug CEO Search.doc Biota Commences CEO Search Melbourne Australia— 29 August 2005.
author: driddell
Microsoft Word - Press release 29 Aug CEO Search.doc page 1
author: driddell
Adult Health Advisor 2004.2: Influenza Adult Health Topics | All Health Topics Find a UMHS Doctor Search Adult Topics Search All Topics This information is approved and/or reviewed by U-M Health System providers but it is not a tool for self-diagnosis or a substitute for medical treatment.
Tryptase TC30, a novel target for influenza therapeutics - - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
Microsoft Word - DTL RELEASE _Draft_.doc Biota appoints Chief Financial Officer Melbourne, Australia— 15 August 2005; Biota Holdings Limited (ASX: BTA) announced today the appointment of Mr.
author: driddell
Microsoft Word - ASX release 15 Aug - German Govt stockpiling of Relenza.doc Biota Confirms Relenza Stockpiling in Germany Melbourne, Australia— 15 August 2005.Relenza has been sold in this single order than over the last five years combined." The order is even larger than the 1.4m units of Relenza sold in its launch year (1999/ 00) when the drug was supported with active promotion by GSK.
author: driddell
Microsoft Word - ASX release 15 Aug - German Govt stockpiling of Relenza.doc page 2
author: driddell
Microsoft Word - ASX release 15 Aug - German Govt stockpiling of Relenza.doc page 1
author: driddell
Preview of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy - Thomson Scientific Thomson.com - - - - - Advanced Search - - - EN : JP : CN : KR -- - - Thomson Scientific : Meeting Previews : 2003 : Preview of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy PREVIEW OF THE 43RD INTERSCIENCE CONFERENCE ON ANTIMICROBIAL AGENTS AND CHEMOTHERAPY Chicago, IL, USA, 14 Sep 2003 Date: 14-17 September 2003 Location: Chicago, IL, USA Coverage The...
http://www.biosis.org/ts/media/cdjournals/gazettenews/2001/CPG_News_0152.pdf New Year greetings to our friends and customers are accompanied by a deep sigh of relief, a consequence of our observation that the number of PCT applications published during 2001 fell marginally short of 100,000.
http://www.biosis.org/ts/media/cdjournals/gazettenews/2004/CPG_News_0419.pdf www.current-patents.com ISSN:1464-3499 The records appearing in this Gazette will be added to DOLPHIN, the Database Of alL PHarmaceutical INventions.zanamivir suffi- ciently is the subject of litigation filed by Australian...
Microsoft Word - PLD release 27 July final.doc Biota Values Claim against GSK at $308 to $430 million Melbourne, Australia, 27 July 2005 Biota Holdings Limited (ASX: BTA) announced today its Particulars of Loss and Damage in its suit against GlaxoSmithKline (GSK) for failing to support Biota's influenza drug, Relenza. Relenza would have achieved a 40% market share and that GSK had...
author: pmolloy
Microsoft Word - PLD release 27 July final.doc page 1
author: pmolloy
